Skip to main navigation

Investors and Media

Form 8937

Date Title
Dec 18, 2014
Forms 8937 for Preferred Shares 671.5 KB
Dec 18, 2014
Forms 8937 for Common Shares 646.6 KB

Investors and Media

  • Investor Overview
  • Stock Information
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • SEC Filings
  • Financial Information
    • Form 8937
  • Shareholder Services
  • Investor FAQs

Kyntra Bio, Inc.

Volume:

Minimum 15 minutes delayed. Source: LSEG

Investor and Media Contact

  • Investors:
    David DeLucia, CFA
    Chief Financial Officer
    ir@kyntrabio.com

Shareholder Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • Terms of Use
  • Privacy Notice
  • About Us
  • Focus Area
  • Pipeline
  • Clinical Trials
  • Investors and Media
  • Terms of Use
  • Privacy Notice
  • © 2026 Kyntra Bio, Inc.
  • 350 Bay St, Ste 100 # 6009 San Francisco, CA 94133 USA